The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenedrive Share News (GDR)

Share Price Information for Genedrive (GDR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.375
Bid: 4.25
Ask: 4.50
Change: 0.00 (0.00%)
Spread: 0.25 (5.882%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 4.375
GDR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Stocks edge higher in cautious end to busy week

Fri, 18th Mar 2022 16:53

(Alliance News) - European equities closed slightly higher on Friday, ending a stacked week in slightly muted fashion, though stocks grew in confidence over the course of the afternoon after Chinese leader Xi Jinping condemned Russia's invasion of Ukraine.

Equities have faced two major central bank decisions this week, as well as ongoing geopolitical tensions. Recent developments concerning the latter have done little to lift hopes that a resolution is near. However, stocks still made decent gains over the course of this week.

The FTSE 100 index ended up 19.39 points, or 0.3%, at 7,404.73 on Friday. The mid-cap FTSE 250 index closed up 180.93 points, or 0.9%, at 21,156.62. The AIM All-Share index rose 9.72 points, or 1.0%, at 1,035.05.

For the week, the blue-chip index has risen 3.5%. The FTSE 250 has added 4.7% and the AIM All-Share has advanced 4.0%.

The Cboe UK 100 index ended up 0.3% at 735.70. The Cboe 250 closed up 0.6% at 18,645.88, and the Cboe Small Companies rose 0.7% at 14,773.20.

In mainland Europe, the CAC 40 stock index in Paris rose 0.1%, while the DAX 40 in Frankfurt rose 0.2%.

The FTSE 100, CAC and DAX were all lower for much of the day, but found their groove in afternoon trade.

Equities in New York were mixed at the time of the European close.

The Dow Jones Industrial Average was down 0.2%, while the S&P 500 was up 0.3% and the Nasdaq Composite advanced 1.1%.

"European and US stocks have continued to recover more of their lost ground this week, despite there being little prospect of a ceasefire, or imminent cessation of hostilities between Russia and Ukraine," CMC Markets analyst Michael Hewson commented.

"As we head into the weekend, we have retreated from the highs of the week on rising scepticism that Russia's interest in a negotiated agreement is in any way serious, although the FTSE 100 is proving to be slightly more resilient."

Chinese leader Xi Jinping said war is "in no one's interest" during a phone call Friday with Joe Biden in which the US president aimed to pressure Beijing into joining Western condemnation of Russia's invasion of Ukraine.

The 1:50 hour-long phone call ended at 1453 GMT in Washington, the White House said.

State broadcaster CCTV reported Xi saying during the call that "state-to-state relations cannot go to the stage of military hostilities."

China and the US should "shoulder international responsibilities," Xi was quoted as saying, as well as declaring that "peace and security are the most valued treasures of the international community."

It was not immediately clear if Xi made any direct criticism of Russian President Vladimir Putin's onslaught against Ukraine or expressed willingness to assist the US-led pressure campaign on the Kremlin.

The call came after rescue workers searched desperately for any survivors buried beneath the rubble of Mariupol's bombed-out theatre Friday, as Russia's forces pounded residential areas across Ukraine, stoking allegations of war crimes.

In the wake of the attack, US Secretary of State Antony Blinken also said it was "difficult to conclude" that Vladimir Putin's regime had not engaged in war crimes by targeting civilians.

Russia has routinely denied that it is targeting civilians, claiming without evidence that hardline Ukrainian nationalists blew up the theatre in Mariupol.

The dollar was mixed at the end of the week.

The pound rose to USD1.3178 late on Friday, from USD1.3155 at the London equities close Thursday. The euro was priced at USD1.1061, lower against USD1.1113.

Against the Japanese yen, the dollar quoted at JPY119.15 in London, up from JPY118.44. The dollar hit JPY119.39, its best level since 2016.

In London, Ted Baker shares rose 17%. Sycamore Partners Management confirmed a Sky News press report that it was in early stages of considering making a possible cash offer for the fashion retailer.

Sycamore Partners said it was considering a possible cash offer for Ted Baker but noted there was no certainty any offer would be made.

In response, Ted Baker confirmed that it had not received any approach from Sycamore. Further, the retailer said it was confident in its independent prospects and would evaluate any offer against the shareholder value creation which it believes can be delivered as a standalone company.

In a positive read-across, Mulberry rose 8.5%.

AJ Bell analyst Russ Mould commented: "It looks like someone might bring an end to Ted Baker's horrific time as a listed company. US private equity group Sycamore is weighing up an offer, perhaps drawn to the fact the clothing retailer’s share price had halved between September 2021 and February this year.

"Ted Baker's fortunes have collapsed in recent years. First came the hugging incident where founder Ray Kelvin was accused of inappropriate behaviour towards staff. Then the company was besieged by a series of profit warnings, a new chief executive who lasted less than a year, and accounting errors where it overstated the value of its inventory. It was forced to slash prices to compete in a heavily discounted market, which really hurt profit margins. Sycamore appears to have spotted an opportunity to step in and buy the company while its valuation remains low and to help with the recovery efforts."

JD Wetherspoon overcame share price weakness in early trade to close up 1.9%.

It reported a narrowed interim loss, but the pub chain is yet to return to the business seen in pre-pandemic times.

Revenue for the half-year that ended January 23 came in at GBP807.4 million, nearly double the GBP431.1 million posted a year before. However, sales remain below the GBP933.0 million achieved two years ago, a pre-pandemic period.

The company posted a pretax loss of GBP21.3 million, narrowed from GBP46.2 million a year ago, but the bottom line remains far off the profit of GBP57.9 million registered two years ago.

On AIM, Simigon shares more than doubled to 3.52 pence from 1.55p on Thursday. The Israel-based software company on Thursday said Gal Erez, a 4% shareholder in the company, eventually backed the firm's acquisition by Power Breezer Sub and Maxify Solutions.

Erez withdrew a restraining order against the firm's merger and share cancellation. The last day of trading of Simigon shares will now be next week Friday. The company agreed to a USD8.5 million takeover back in Janaury.

Genedrive shares more than doubled to 33p from 16.25p on Thursday. The Manchester-based molecular diagnostics company said six installations of its MT-RNR1 Antibiotic Induced Hearing Loss system have been deployed to the Manchester University NHS Foundation Trust.

The system screens infants for a genetic mutation which can cause lifelong hearing loss if carriers are given antibiotics.

"MFT will become the first NHS trust to implement the technology into routine clinical care," Genedrive said.

Brent oil was quoted at USD107.51 a barrel at the London equities close on Friday, up from USD106.62 on Thursday. Gold stood at USD1,938.46 an ounce, lower against USD1,942.97.

Monday's UK corporate calendar has annual results from photobooth operator Photo-Me International PLC, while recruiter SThree posts a trading statement.

The economic events calendar has the latest interest rate announcement from the People's Bank of China overnight, before producer price data from Germany at 0700 GMT. Financial markets in Japan are closed to mark Vernal Equinox Day.

The week picks up pace with UK inflation data on Wednesday, and a deluge of flash PMIs on Thursday.

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
20 Dec 2023 11:07

AIM WINNERS & LOSERS: Genedrive shares jump on orders

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
20 Dec 2023 10:49

IN BRIEF: Genedrive shares surge as six countries receive first orders

Genedrive PLC - Manchester, England-based molecular diagnostics company - Says initial orders of its MT-RNR1 products from France, Austria, the Netherlands, Greece, Saudi Arabia and Turkey have been received. News follows confirmation that commercial distribution agreements were signed in multiple countries for Genedrive's test for antibiotic induced hearing loss. Genedrive says these initial orders will support its international distribution partners in promotion and in-country evaluation activities in their respective countries. Hopes this will "provide more extensive access to this life-changing test."

Read more
4 Dec 2023 17:33

TRADING UPDATES: 600 Group disposal and funding talks continue

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
30 Nov 2023 10:03

Genedrive shares fall as annual loss widens but focused on investing

(Alliance News) - Genedrive PLC on Thursday reported a widened loss but said it remains focused on investing in product development, focusing on maximising the benefits of its platform.

Read more
29 Nov 2023 21:36

EARNINGS AND TRADING: Southern Energy loss swing; Craven House widens

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
23 Nov 2023 15:54

UK earnings, trading statements calendar - next 7 days

Friday 24 November 
no events scheduled 
Monday 27 November 
Celebrus Technologies PLCHalf Year Results
DSW Capital PLCHalf Year Results
JLEN Environmental Assets Group LtdHalf Year Results
Northern Bear PLCHalf Year Results
Rightmove PLCTrading Statement
Serinus Energy PLCQ3 Results
SysGroup PLCHalf Year Results
Tuesday 28 November 
Altitude Group PLCHalf Year Results
Augmentum FintechHalf Year Results
Brickability Group PLCHalf Year Results
DP Eurasia NVTrading Statement
easyJet PLCFull Year Results
Focusrite PLCFull Year Results
Greencore Group PLCFull Year Results
IG Design Group PLCHalf Year Results
Kinovo PLCHalf Year Results
Loungers PLCHalf Year Results
Mercia Asset Management PLCHalf Year Results
Pets At Home Group PLCHalf Year Results
Renew Holdings PLCFull Year Results
Safestore Holdings PLCTrading Statement
Supreme PLCHalf Year Results
Topps Tiles PLCFull Year Results
Treatt PLCFull Year Results
Vp PLCHalf Year Results
Wednesday 29 November 
Amaroq Minerals LtdQ3 Results
Benchmark Holdings PLCFull Year Results
Braemar PLCHalf Year Results
Cordiant Digital Infrastructure LtdHalf Year Results
CVS Group PLCTrading Statement
Halfords Group PLCHalf Year Results
Harbour Energy PLCTrading Statement
Pennon Group PLCHalf Year Results
Vinanz LtdQ3 Results
Thursday 30 November 
Carclo PLCHalf Year Results
Dr Martens PLCHalf Year Results
Genedrive PLCFull Year Results
James Latham PLCHalf Year Results
LXi REIT PLCHalf Year Results
ME Group International PLCTrading Statement
TClarke PLCTrading Statement
Tharisa PLCFull Year Results
Walker Crips Group PLCHalf Year Results
Zoo Digital Group PLCHalf Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
28 Sep 2023 16:09

IN BRIEF: Genedrive to receive GBP1.2 million grant for test kit

Genedrive PLC - Manchester-based molecular diagnostics company - Confirms that it expects to benefit from GBP1.2 million of funding, through its participation in a multi-partner grant award from Innovate UK and the UK government Innovation Accelerator programme. The grant, which is for the development and validation of technology for time critical genomic testing, will provide Genedrive with acute care patient access and supporting infrastructure to assess the real world clinical performance of time-critical clinical tests in NHS settings.

Read more
11 Sep 2023 15:21

Genedrive appoints new chief executive and chief scientific officer

(Alliance News) - Genedrive PLC on Monday said it appointed James Cheek as its new chief executive officer, effective immediately.

Read more
6 Sep 2023 13:55

Genedrive diagnostic test system gets UKCA registration

(Sharecast News) - Point-of-care molecular diagnostics developer Genedrive announced on Wednesday that its Genedrive CYP2C19 System has received UKCA marking registration.

Read more
6 Sep 2023 11:18

Genedrive shares jump as hails UKCA mark for test; aims for EU CE mark

(Alliance News) - Genedrive PLC on Wednesday said that its CYP2C19 point of care test achieved marking registration in the UK, known as UKCA.

Read more
5 Jul 2023 15:30

TRADING UPDATES: RTW plans buyback; Octopus AIM VCTs eye fundraise

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
5 Jul 2023 14:41

Genedrive draws down £0.3m under equity prepayment facility

(Sharecast News) - Molecular diagnostics company Genedrive announced the latest drawdown of £0.3m under its £5m equity prepayment facility on Wednesday.

Read more
16 Jun 2023 10:49

Genedrive secures multi-partner grant award

(Sharecast News) - Molecular diagnostics specialist Genedrive announced its involvement in a multi-partner grant award called DEVOTE on Friday, supported by Innovate UK and the UK government's Innovation Accelerator programme.

Read more
16 Jun 2023 10:29

AIM WINNERS & LOSERS: Marlowe up on report of potential division sale

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
16 Jun 2023 09:27

IN BRIEF: Genedrive shares up as UK government grant received

Genedrive PLC - Manchester, England-based point-of-care molecular diagnostics company - Awarded a multi-partner grant for the validation of its CYP2X19 ID kit from Innovate UK and the UK government Innovation Accelerator programme. Says the 'Devote' grant will allow it to offer critical clinical tests in NHS settings.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.